NCT01694732View on ClinicalTrials.gov

Efficacy of Varenicline on Smoking Cessation at the Acute Phase of an Exacerbation of Chronic Obstructive Pulmonary Disease

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions

Chronic Obstructive Pulmonary DiseaseCOPD ExacerbationSmoking

Interventions

DRUG

Varenicline

DRUG

placebo

Trial Locations (13)

22027

Saint Brieuc Hospital, Saint-Brieuc

29107

Cornouaille Hospital, Quimper

29200

Hôpital HIA Clermont Tonnerre, Brest

29609

Cavale Blanche Hospital, Brest

30029

Caremeau Hospital, Nîmes

35033

Pontchaillou, Rennes

37044

Bretonneau Hospital, Tours

44093

Laennec Hospital, Nantes

49933

CHU Angers, Angers

59037

CHRU Lille, Lille

75004

Hotel Dieu Hospital, Paris

75015

HEGP Hospital, Paris

86021

Poitiers Hospital, Poitiers

All Listed Sponsors

lead

University Hospital, Brest

OTHER

NCT01694732 - Efficacy of Varenicline on Smoking Cessation at the Acute Phase of an Exacerbation of Chronic Obstructive Pulmonary Disease | Biotech Hunter | Biotech Hunter